I am a cardiology fellow at the Texas Heart Institute. I graduated with a degree in computer science with Honors from Bucknell University and a Masters of Science in Bioinformatics from Indiana University. I received my medical degree from the Indiana University School of Medicine and completed internal medicine residency at UT Southwestern. My current research focuses on using machine learning and artificial intelligence to improve risk prediction and tailor medical therapies to identify and treat heart failure.
Mediation analyses of the effect of ertugliflozin on hospitalisation for heart failure in patients with type 2 diabetes and atherosclerotic cardiovascular disease from the VERTIS CV trial
Event: ESC Congress 2021 - The Digital Experience
Topic: Pharmacotherapy
Session: Can we improve outcomes by targeting metabolic risk?
ESC 365 is supported by
